Delek US (DK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 May, 2026Voting matters and shareholder proposals
Nine directors are nominated for election, with the board recommending a vote in favor of each nominee.
Advisory approval of the executive compensation program for named executive officers is proposed, with board support.
Approval of the 2026 Long-Term Incentive Plan is up for vote, recommended by the board.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026 is proposed, with board endorsement.
Board of directors and corporate governance
The slate includes nine nominees for the board, reflecting a mix of experience and backgrounds.
Executive compensation and say-on-pay
Shareholders are asked to approve, on an advisory basis, the executive compensation program as described in the proxy materials.
A new 2026 Long-Term Incentive Plan is proposed for approval, aiming to align executive interests with shareholder value.
Latest events from Delek US
- Q2 2026 saw robust earnings, margin expansion, and continued capital returns amid volatility.DK
Q2 2026 - Adjusted EBITDA rose to $211.7M as refining margins improved and operational execution strengthened.DK
Q1 2026 - All management proposals passed, including director elections and incentive plan approval.DK
AGM 2026 - 2026 incentive plan share increase reduced to 1,300,000 after ISS feedback.DK
Proxy filing - Board recommends voting for all proposals, highlighting governance, compensation, and ESG focus.DK
Proxy Filing - Q4 2025 saw robust EBITDA and cash flow gains, driven by EOP and regulatory relief.DK
Q4 2025 - Q2 net loss, record throughput, and asset sales to deliver $500M+ cash inflow.DK
Q2 2024 - Q3 2024: $93M adjusted net loss, record Logistics EBITDA, retail sale, and $100M optimization plan.DK
Q3 2024 - Q4 net loss of $414M, but logistics growth and cost actions set up stronger 2025 cash flow.DK
Q4 2024